World's Best Scientists 2026 revealed!
Michael F. Good

Michael F. Good

D-Index & Metrics

Immunology

D-Index
75
Citations
18569
World Ranking
1994
National Ranking
77

Medicine

D-Index
75
Citations
18581
World Ranking
19183
National Ranking
645

Michael F. Good publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael F. Good sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 428 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael F. Good D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael F. Good sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael F. Good is affiliated with Griffith University in Australia and has contributed extensively to the field of Medicine, focusing primarily on Public Health, Environmental and Occupational Health, Infectious Diseases, Molecular Biology, Immunology, and Parasitology. Their research output includes a significant number of publications in these areas, addressing various pressing health challenges.

Their recent published papers include:

  • Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines, 2020, Science Advances
  • Rheumatic heart disease: A review of the current status of global research activity, 2020, Autoimmunity Reviews
  • A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study, 2021, The Lancet Microbe
  • Malaria Vaccines: Progress to Date, 2023, BioDrugs
  • Nonessential Research in the New Normal: The Impact of COVID-19, 2020, American Journal of Tropical Medicine and Hygiene

Michael F. Good's work spans several main topics, including:

  • Streptococcal Infections and Treatments
  • Antimicrobial Resistance in Staphylococcus
  • Inflammasome and immune disorders
  • Neonatal and Maternal Infections
  • Malaria Research and Control
  • Mosquito-borne diseases and control
  • SARS-CoV-2 and COVID-19 Research

The scientist frequently collaborates with multiple coauthors such as:

  • Manisha Pandey
  • Victoria Ozberk
  • Ainslie Calcutt
  • Danielle I. Stanisic
  • Jessica Dooley

Publications have often appeared in venues including:

  • mBio
  • bioRxiv (Cold Spring Harbor Laboratory)
  • npj Vaccines
  • Scientific Reports
  • Nature Communications

In addition to journal articles, Michael F. Good has contributed to book publications, including a title published by Fordham University Press eBooks:

  • The Search for Major Plagge, 2022

This profile outlines the comprehensive range of Michael F. Good's research activities and collaborations within the medical sciences, with a focus on infectious diseases and immunology among other related fields.

Best Publications

  • CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites

    Walter R. Weiss;Martha Sedegah;Richard L. Beaudoin;Louis H. Miller

  • Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.

    David J Pombo;David J Pombo;Gregor Lawrence;Chakrit Hirunpetcharat;Christine Rzepczyk

  • Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule

    Michael F. Good;David Pombo;Isabella A. Quakyi;Eleanor M. Riley

  • Immune effector mechanisms in malaria.

    Michael F Good;Denise L Doolan

  • Malaria vaccine developments.

    Vasee S. Moorthy;Michael F. Good;Adrian V.S. Hill

  • Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes.

    W R Weiss;S Mellouk;R A Houghten;M Sedegah

  • Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research

    Michael Francis Good;Huji Xu;Michelle Wykes;Christian R. Engwerda

  • Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus.

    Wendy A. Hayman;Evelyn R. Brandt;Wendy A. Relf;Juan Cooper

  • PATHWAYS AND STRATEGIES FOR DEVELOPING A MALARIA BLOOD-STAGE VACCINE*

    Michael F. Good;David C. Kaslow;Louis H. Miller

  • A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria

    Fiona H. Amante;Amanda C. Stanley;Louise M. Randall;Louise M. Randall;Yonghong Zhou

  • Immune-Mediated Mechanisms of Parasite Tissue Sequestration during Experimental Cerebral Malaria

    Fiona H Amante;Ashraful K M Nazmul Haque;Amanda C Stanley;Fabian De Labastida Rivera

  • Protection against Group A Streptococcus by Immunization with J8-Diphtheria Toxoid: Contribution of J8- and Diphtheria Toxoid-Specific Antibodies to Protection

    Michael R Batzloff;Wendy A Hayman;Mark R Davies;Ming Zeng

  • The Mechanism and Significance of Deletion of Parasite-specific CD4+ T Cells in Malaria Infection

    Huji Xu;Jiraprapa Wipasa;Huaru Yan;Ming Zeng

  • Polyacrylate Dendrimer Nanoparticles: A Self-Adjuvanting Vaccine Delivery System

    Mariusz Skwarczynski;Mehfuz Zaman;Carl N. Urbani;I-Chun Lin

  • New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.

    Evelyn R. Brandt;K.S. Sriprakash;Rhonda I. Hobb;Wendy A. Hayman

  • Challenges and strategies for developing efficacious and long-lasting malaria vaccines

    James G. Beeson;James G. Beeson;James G. Beeson;Liriye Kurtovic;Liriye Kurtovic;Carlota Dobaño;D. Herbert Opi;D. Herbert Opi

  • Protein Antigenic Structures Recognized by T Cells; Potential Applications to Vaccine Design

    Jay A. Berzofsky;Kemp B. Cease;James L. Cornette;John L. Spouge

  • The relevance of non-human primate and rodent malaria models for humans

    Jean Langhorne;Pierre Buffet;Mary Galinski;Michael Francis Good

  • Towards a blood-stage vaccine for malaria: are we following all the leads?

    Michael F. Good

  • A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy

    K. A. O. Ellem;Michael G. E. O’Rourke;Gregory R. Johnson;Gordon Parry

  • New Generation Vaccines, Fourth Edition

    Myron Levine;Gordon Dougan;Michael Good;Margaret Liu

Frequent Co-Authors

Istvan Toth
Istvan Toth University of Queensland
Christian R. Engwerda
Christian R. Engwerda QIMR Berghofer Medical Research Institute
James S. McCarthy
James S. McCarthy Walter and Eliza Hall Institute of Medical Research
Denise L. Doolan
Denise L. Doolan Australian Institute of Tropical Health and Medicine
Louis H. Miller
Louis H. Miller National Institute of Allergy and Infectious Diseases
Michael P. Pender
Michael P. Pender University of Queensland
Jonathan R. Carapetis
Jonathan R. Carapetis Telethon Kids Institute
David C. Kaslow
David C. Kaslow United States Food and Drug Administration
Nicholas M. Anstey
Nicholas M. Anstey Charles Darwin University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with various healthcare and nursing pathways. For those interested in advancing their clinical expertise, understanding options like how to transition from fnp to acute care certification can be crucial. This certification allows nurse practitioners to specialize in acute patient care, broadening their scope in immunology-related fields.

Many aspiring healthcare professionals start with foundational programs such as online bsn programs for non nurses, which offer accessible routes for those shifting careers toward nursing and immunology. These programs help non-nurses gain essential clinical knowledge to support advanced studies.

For those aiming to fast-track their nursing careers, the availability of accelerated np programs provides efficient pathways to become nurse practitioners, often with a focus on specialized fields like immunology and infectious diseases.

Salary outlooks are an important consideration when pursuing these careers. Understanding variations such as the dnp salary by state can help students and professionals make informed decisions about where to study and work, maximizing both educational investment and career growth.

Best Scientists Citing Michael F. Good

Trending Scientists

Recently Published Articles